argenx SE American Depositary Shares (ARGX) Stock Price

ARGXStock

$1019.49+43.41%52W

Market Cap$63.40B

P/E42.51x

PEG Ratio1.63

Div yield—

Beta1.49

ARGX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)9.18%

Price vs S&P 500 (4W)8.89%

PEG Ratio1.63

VGM Score63.17

P/E Ratio (Annual)42.51x

P/CF (Annual)80.16x

Book Value / Share (Quarterly)$134.59

P/TBV (Annual)7.18x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)116.21%

Cash Flow / Share (Quarterly)$13.11

Price vs S&P 500 (YTD)9.97%

Gross Margin (TTM)139.03%

Net Profit Margin (TTM)47.37%

EPS (TTM)$37.84

10-Day Avg Trading Volume0.08M

EPS Excl Extra (TTM)$37.84

Revenue Growth (5Y)151.52%

EPS (Annual)$19.57

ROI (Annual)17.53%

Gross Margin (Annual)89.14%

Net Profit Margin (5Y Avg)-41.95%

Cash / Share (Quarterly)$82.89

P/E Basic Excl Extra (TTM)22.19x

Revenue Growth QoQ (YoY)59.71%

P/E Normalized (Annual)42.51x

ROA (Last FY)14.88%

Revenue Growth TTM (YoY)71.28%

EBITD / Share (TTM)$24.51

ROE (5Y Avg)-3.15%

Operating Margin (TTM)43.76%

Cash Flow / Share (Annual)$9.27

P/B Ratio6.53x

P/B Ratio (Quarterly)6.92x

Net Income / Employee (Annual)$808,000

EV / Revenue (TTM)18.35x

Net Interest Coverage (TTM)-81.88x

ROA (TTM)18.86%

EPS Growth QoQ (YoY)102.60%

EV / EBITDA (TTM)32.63x

EPS Incl Extra (Annual)$19.57

Current Ratio (Annual)5.23x

Quick Ratio (Quarterly)4.52x

3-Month Avg Trading Volume0.09M

52-Week Price Return43.41%

EV / Free Cash Flow (Annual)89.60x

P/E Incl Extra (TTM)22.19x

Revenue / Employee (TTM)$3,268,100

Tangible BV / Share (Quarterly)$130.34

P/S Ratio (Annual)13.23x

Asset Turnover (Annual)0.48x

52-Week High$903.00

Operating Margin (5Y Avg)-51.15%

EPS Excl Extra (Annual)$19.57

CapEx CAGR (5Y)85.11%

Tangible BV CAGR (5Y)36.16%

26-Week Price Return20.43%

Quick Ratio (Annual)4.62x

13-Week Price Return24.49%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)5.12x

Enterprise Value$51.39B

Revenue / Share Growth (5Y)133.37%

Asset Turnover (TTM)0.30x

Book Value / Share Growth (5Y)27.45%

Revenue / Employee (Annual)$2,596,200

Inventory Turnover (Annual)1.02x

Pretax Margin (Annual)30.80%

Cash / Share (Annual)$71.75

3-Month Return Std Dev50.78%

Net Income / Employee (TTM)$1,548,000

EBITDA Interim CAGR (5Y)38.90%

ROE (Last FY)17.64%

Net Interest Coverage (Annual)5.58x

EPS Basic Excl Extra (Annual)$19.57

P/FCF (TTM)67.00x

Receivables Turnover (TTM)3.53x

EV / Free Cash Flow (TTM)62.69x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$37.84

Receivables Turnover (Annual)3.60x

ROI (TTM)22.29%

P/S Ratio (TTM)10.51x

Pretax Margin (5Y Avg)-49.62%

Revenue / Share (Annual)$62.87

Tangible BV / Share (Annual)$113.94

Forward P/E27.19x

Price vs S&P 500 (52W)25.10%

P/E Ratio (TTM)22.19x

EPS Growth TTM (YoY)95.72%

Year-to-Date Return20.56%

5-Day Price Return-0.67%

EPS Normalized (Annual)$19.57

ROA (5Y Avg)-3.03%

Net Profit Margin (Annual)31.12%

Month-to-Date Return16.00%

EBITD / Share (Annual)$16.26

Operating Margin (Annual)25.38%

LT Debt / Equity (Annual)0.32x

P/CF (TTM)56.37x

ROI (5Y Avg)-3.15%

P/E Excl Extra (TTM)22.19x

EPS Basic Excl Extra (TTM)$37.84

P/TBV (Quarterly)7.14x

P/B Ratio (Annual)6.92x

Inventory Turnover (TTM)2.32x

Pretax Margin (TTM)50.19%

Book Value / Share (Annual)$118.34

Price vs S&P 500 (13W)21.69%

Beta1.49x

P/FCF (Annual)95.77x

Revenue / Share (TTM)$83.66

ROE (TTM)22.43%

52-Week Low$568.40

vGradeD

gGradeA

mGradeB

vgmGradeB

ARGX Earnings Surprise History

Q2 253.74est. 3.02

Q3 255.18est. 4.16

Q4 258.02est. 6.11

Q1 265.52est. 4.92

Q2 267.32est. 6.19

ARGX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.24

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	C	$14.56

About argenx SE American Depositary Shares

Argenx is a Dutch biopharmaceutical company developing antibody-based therapies for rare autoimmune and immune-mediated diseases. Its lead product, Vyvgart (efgartigimod), is FDA-approved for generalized myasthenia gravis, with the subcutaneous formulation Vyvgart Hytrulo also approved for chronic inflammatory demyelinating polyneuropathy. The company's pipeline includes candidates for primary immune thrombocytopenia, thyroid eye disease, and Sjögren's disease.